Gene variants linked to psychotic disorders may affect how bodies process common drugs

Researchers identified six genetic variants in a transporter protein that could influence how psychiatric patients metabolize medications. The finding matters for drug developers and healthcare systems: personalized dosing based on these variants could improve treatment safety and effectiveness for people with psychosis.

Originaltitel: Functional Characterization of Six<i> SLCO1B1</i> (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder